Companies / BOC Sciences / Labetuzumab
BOC Sciences

Labetuzumab | BOC Sciences

Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with antineoplastic activity. Labetuzumab has been used as an adjuvant treatment for colorectal cancer.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
  • See More